These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31179326)

  • 1. Eupatilin Inhibits Renal Cancer Growth by Downregulating MicroRNA-21 through the Activation of YAP1.
    Zhong W; Wu Z; Chen N; Zhong K; Lin Y; Jiang H; Wan P; Lu S; Yang L; Liu S
    Biomed Res Int; 2019; 2019():5016483. PubMed ID: 31179326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anticancer Effect of Huaier Extract in Renal Cancer 786-O Cells.
    Wei C; Liu Z; Li L; Zhang Y; Fang Z; Fan Y
    Pharmacology; 2018; 102(5-6):316-323. PubMed ID: 30296782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer effect of eupatilin on glioma cells through inhibition of the Notch-1 signaling pathway.
    Wang Y; Hou H; Li M; Yang Y; Sun L
    Mol Med Rep; 2016 Feb; 13(2):1141-6. PubMed ID: 26676446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation-mediated miR-214 regulates proliferation and drug sensitivity of renal cell carcinoma cells through targeting LIVIN.
    Xu H; Wu S; Shen X; Shi Z; Wu D; Yuan Y; Jiang W; Wang Q; Ke Q; Mao Q; Li X; Liu Y; Yuan P; Zhang Q; Huang E; Chen X
    J Cell Mol Med; 2020 Jun; 24(11):6410-6425. PubMed ID: 32395888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
    Deng W; Han W; Fan T; Wang X; Cheng Z; Wan B; Chen J
    Biomed Pharmacother; 2018 Nov; 107():1505-1513. PubMed ID: 30257368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eupatilin Inhibits the Proliferation and Migration of Prostate Cancer Cells through Modulation of PTEN and NF-κB Signaling.
    Serttas R; Koroglu C; Erdogan S
    Anticancer Agents Med Chem; 2021; 21(3):372-382. PubMed ID: 32781972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma.
    Wang X; Jiang F; Song H; Li X; Xian J; Gu X
    Biochem Biophys Res Commun; 2016 Feb; 470(3):620-626. PubMed ID: 26797273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
    Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
    Li G; Chong T; Xiang X; Yang J; Li H
    Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces cell cycle arrest in ras-transformed human mammary epithelial cells.
    Kim DH; Na HK; Oh TY; Kim WB; Surh YJ
    Biochem Pharmacol; 2004 Sep; 68(6):1081-7. PubMed ID: 15313404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of MicroRNA-381 Promotes Tumor Cell Growth and Chemoresistance in Clear-Cell Renal Cell Carcinoma.
    Chan Y; Yu Y; Wang G; Wang C; Zhang D; Wang X; Wang Z; Jian W; Zhang C
    Med Sci Monit; 2019 Jul; 25():5181-5190. PubMed ID: 31299041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-Regulation of Circular RNA_000926 Attenuates Renal Cell Carcinoma Progression through miRNA-411-Dependent CDH2 Inhibition.
    Zhang D; Yang XJ; Luo QD; Fu DL; Li ZL; Zhang P; Chong T
    Am J Pathol; 2019 Dec; 189(12):2469-2486. PubMed ID: 31476285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.
    Pengcheng S; Ziqi W; Luyao Y; Xiangwei Z; Liang L; Yuwei L; Lechen L; Wanhai X
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eupatilin, a major flavonoid of Artemisia, attenuates aortic smooth muscle cell proliferation and migration by inhibiting PI3K, MKK3/6, and MKK4 activities.
    Son JE; Lee E; Seo SG; Lee J; Kim JE; Kim J; Lee KW; Lee HJ
    Planta Med; 2013 Aug; 79(12):1009-16. PubMed ID: 23877919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
    Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
    Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
    Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
    J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
    Li Z; Ma Z; Xu X
    Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-590-5p regulates cell viability, apoptosis, migration and invasion of renal cell carcinoma cell lines through targeting ARHGAP24.
    Wang L; Wei WQ; Wu ZY; Wang GC
    Mol Biosyst; 2017 Nov; 13(12):2564-2573. PubMed ID: 29019371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-140-5p and miR-92a-3p suppress the cell proliferation, migration and invasion and promoted apoptosis in Wilms' tumor by targeting FRS2.
    Li JL; Luo P
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):97-108. PubMed ID: 31957822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of MicroRNA-218 on the viability, apoptosis and invasion of renal cell carcinoma cells under hypoxia by targeted downregulation of CXCR7 expression.
    Zhang S; Hong Z; Li Q; Lei J; Huang H; Liu Q
    Biomed Pharmacother; 2016 May; 80():213-219. PubMed ID: 27133059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.